Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glucose, quantity: 50 g - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glucose, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 70% - solution for infusion - 70 % - active: glucose monohydrate 70% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - glucose monohydrate - solution for infusion - 5 %w/v - electrolytes with carbohydrates

Malta - Kiingereza - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, glucose monohydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l glucose monohydrate 33.3 g/l magnesium chloride hexahydrate 0.051 g/l sodium chloride 21.12 g/l sodium hydrogen carbonate 2.1 g/l sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Malta - Kiingereza - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, glucose monohydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, sodium lactate - solution for peritoneal dialysis - calcium chloride 0.257 g/l glucose monohydrate 42.5 g/l magnesium chloride hexahydrate 0.051 g/l sodium chloride 5.67 g/l sodium hydrogen carbonate 2.1 g/l sodium lactate 1.12 g/l - blood substitutes and perfusion solutions

Malta - Kiingereza - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, glucose monohydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, sodium lactate - solution for peritoneal dialysis - calcium chloride 0.184 g/l glucose monohydrate 15 g/l magnesium chloride hexahydrate 0.051 g/l sodium chloride 5.38 g/l sodium hydrogen carbonate 2.1 g/l sodium lactate 1.68 g/l - blood substitutes and perfusion solutions